Literature DB >> 33179832

Predicting Isocitrate Dehydrogenase (IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features.

Hong Peng1,2, Jiaohua Huo3, Bo Li4, Yuanyuan Cui1,2, Hao Zhang1,2, Liang Zhang3, Lin Ma1,2.   

Abstract

BACKGROUND: Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging.
PURPOSE: To establish a model for classifying IDH status in gliomas based on multiparametric MRI. STUDY TYPE: Retrospective, radiomics. POPULATION: In all, 105 consecutive cases of grade II-IV glioma with 50 IDH1 or IDH2 mutant (IDHm) and 55 IDH wildtype (IDHw) were separated into a training cohort (n = 73) and a test cohort (n = 32). FIELD STRENGTH/SEQUENCE: Contrast-enhanced T1 -weighted (CE-T1 W), T2 -weighted (T2 W), and arterial spin labeling (ASL) images were acquired at 3.0T. ASSESSMENT: Two doctors manually labeled the volume of interest (VOI) on CE-T1 W, then T2 W and ASL were coregistered to CE-T1 W. A total of 851 radiomics features were extracted on each VOI of three sequences. From the training cohort, all radiomics features with age and gender were processed by the Mann-Whitney U-test, Pearson test, and least absolute shrinkage and selection operator to obtain optimal feature groups to train support vector machine models. The accuracy and area under curve (AUC) of all models for classifying the IDH status were calculated on the test cohort. Two subtasks were performed to verify the efficiency of texture features and the Pearson test in IDH status classification, respectively. STATISTICAL TESTS: The permutation test with Bonferroni correction; chi-square test.
RESULTS: The accuracy and AUC of the classifier, which combines the features of all three sequences, achieved 0.823 and 0.770 (P < 0.05), respectively. The best model established by texture features only had an AUC of 0.819 and an accuracy of 0.761. The best model established without the Pearson test got an AUC of 0.747 and an accuracy of 0.719. DATA
CONCLUSION: IDH genotypes of glioma can be identified by radiomics features from multiparameter MRI. The Pearson test improved the performance of the IDH classification models. LEVEL OF EVIDENCE: 4 TECHNICAL EFFICACY STAGE: 1.
© 2020 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  IDH; glioma; multiparametric MRI; support vector machine

Mesh:

Substances:

Year:  2020        PMID: 33179832     DOI: 10.1002/jmri.27434

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  9 in total

Review 1.  A Survey of Radiomics in Precision Diagnosis and Treatment of Adult Gliomas.

Authors:  Peng Du; Hongyi Chen; Kun Lv; Daoying Geng
Journal:  J Clin Med       Date:  2022-06-30       Impact factor: 4.964

2.  Probing individual-level structural atrophy in frontal glioma patients.

Authors:  Guobin Zhang; Xiaokang Zhang; Huawei Huang; Yonggang Wang; Haoyi Li; Yunyun Duan; Hongyan Chen; Yaou Liu; Bin Jing; Yanmei Tie; Song Lin
Journal:  Neurosurg Rev       Date:  2022-05-04       Impact factor: 2.800

3.  Non-Invasive Prediction of Survival Time of Midline Glioma Patients Using Machine Learning on Multiparametric MRI Radiomics Features.

Authors:  Da-Biao Deng; Yu-Ting Liao; Jiang-Fen Zhou; Li-Na Cheng; Peng He; Sheng-Nan Wu; Wen-Sheng Wang; Quan Zhou
Journal:  Front Neurol       Date:  2022-05-02       Impact factor: 4.086

Review 4.  Preoperative Diagnosis and Molecular Characterization of Gliomas With Liquid Biopsy and Radiogenomics.

Authors:  Carmen Balana; Sara Castañer; Cristina Carrato; Teresa Moran; Assumpció Lopez-Paradís; Marta Domenech; Ainhoa Hernandez; Josep Puig
Journal:  Front Neurol       Date:  2022-05-26       Impact factor: 4.086

Review 5.  The progress of multimodal imaging combination and subregion based radiomics research of cancers.

Authors:  Luyuan Zhang; Yumin Wang; Zhouying Peng; Yuxiang Weng; Zebin Fang; Feng Xiao; Chao Zhang; Zuoxu Fan; Kaiyuan Huang; Yu Zhu; Weihong Jiang; Jian Shen; Renya Zhan
Journal:  Int J Biol Sci       Date:  2022-05-09       Impact factor: 10.750

6.  Multiparametric MRI-Based Radiomics Model for Predicting H3 K27M Mutant Status in Diffuse Midline Glioma: A Comparative Study Across Different Sequences and Machine Learning Techniques.

Authors:  Wei Guo; Dejun She; Zhen Xing; Xiang Lin; Feng Wang; Yang Song; Dairong Cao
Journal:  Front Oncol       Date:  2022-03-03       Impact factor: 6.244

7.  Magnetic Resonance Imaging Correlates of Immune Microenvironment in Glioblastoma.

Authors:  Alessandro Salvalaggio; Erica Silvestri; Giulio Sansone; Laura Pinton; Sara Magri; Chiara Briani; Mariagiulia Anglani; Giuseppe Lombardi; Vittorina Zagonel; Alessandro Della Puppa; Susanna Mandruzzato; Maurizio Corbetta; Alessandra Bertoldo
Journal:  Front Oncol       Date:  2022-03-22       Impact factor: 6.244

Review 8.  Hemodynamic Imaging in Cerebral Diffuse Glioma-Part B: Molecular Correlates, Treatment Effect Monitoring, Prognosis, and Future Directions.

Authors:  Vittorio Stumpo; Lelio Guida; Jacopo Bellomo; Christiaan Hendrik Bas Van Niftrik; Martina Sebök; Moncef Berhouma; Andrea Bink; Michael Weller; Zsolt Kulcsar; Luca Regli; Jorn Fierstra
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639

9.  Fully Automated MR Based Virtual Biopsy of Cerebral Gliomas.

Authors:  Johannes Haubold; René Hosch; Vicky Parmar; Martin Glas; Nika Guberina; Onofrio Antonio Catalano; Daniela Pierscianek; Karsten Wrede; Cornelius Deuschl; Michael Forsting; Felix Nensa; Nils Flaschel; Lale Umutlu
Journal:  Cancers (Basel)       Date:  2021-12-08       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.